• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. ARTEMIS NEURO EVACUATION DEVICE; GWG

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. ARTEMIS NEURO EVACUATION DEVICE; GWG Back to Search Results
Model Number AP28-A
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Hemorrhage/Bleeding (1888)
Event Date 03/02/2021
Event Type  Death  
Manufacturer Narrative
The product was not returned for evaluation.From the information provided, there is no indication that there was any device malfunction, nonconformance, or misuse that contributed to the reported event.Potential adverse events in the labeling with the artemis neuro evacuation device include, but are not limited to, hydrocephalus, hematoma or hemorrhage at the site, intraventricular hemorrhage, re-bleeding, thromboembolic events, including death.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.
 
Event Description
On (b)(6) 2021, the patient underwent a minimally invasive surgery (mis) procedure in the right parietal and occipital lobes using an artemis neuro evacuation device (artemis).The ultrasound during the procedure showed good evacuation of the hemorrhage, and no procedural complications were reported.The patient remained stable throughout the procedure and remained intubated and sedated while being transferred for a routine post-operative computed tomography (ct) scan of the head.The ct scan revealed a large re-hemorrhage at the same site with extension into the right ventricle.The patient was returned to the operating room (or) and underwent a right craniotomy, evacuation of the re-hemorrhage, and insertion of an external ventricular drain (evd).The patient was then transferred to the neurological critical care unit (nccu).On (b)(6) 2021, the patient demonstrated a worsening in his neurological examination.Immediately following this, the patient had a ct demonstrating new areas of hemorrhage and extensive edema lateral to the primary hemorrhage within the parietal lobe with marked associated midline shift.The patient was transferred to the or for another craniotomy and hemorrhage evacuation.Post-operative ct scan demonstrated further progression of the edema & hemorrhage far lateral to the region of the original hemorrhage and mis procedure.He was returned to the or for extension of his craniectomy with resection of some of the injured brain tissue.Post-op ct showed adequate decompression and reduced midline shift.Magnetic resonance (mr) imaging was completed 3/4 which showed the hemorrhage but no underlying mass.The magnetic resonance angiogram (mra) was reported to be normal.Magnetic resonance venography (mrv) showed patency of the major dural sinuses.Conventional angiography demonstrated an absence of cortical veins over the right parietal and occipital regions.There was no evidence of an arterial vascular lesion or vasculitis to account for this rapidly progressive multifocal hemorrhage and edema.On (b)(6) 2021, the patient could follow some simple commands and was extubated.On (b)(6) 2021, the patient failed to wean and was re-intubated.It was also reported that the patient¿s neurological status was unchanged.Family decided comfort care and the patient was terminally extubated on (b)(6) 2021.The re-hemorrhage and the new cerebral multifocal hemorrhage with edema leading to the patient's expiration were adjudicated to be serious adverse events with a probable relationship to the artemis and a definite relationship to the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARTEMIS NEURO EVACUATION DEVICE
Type of Device
GWG
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
Manufacturer Contact
veronica farris
one penumbra place
alameda, CA 94502
5107483200
MDR Report Key12981477
MDR Text Key282089655
Report Number3005168196-2021-02779
Device Sequence Number1
Product Code GWG
UDI-Device Identifier00814548017877
UDI-Public00814548017877
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K171332
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 01/01/2005,12/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/10/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/22/2021
Device Model NumberAP28-A
Device Catalogue NumberAP28
Device Lot NumberS10007
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Date Manufacturer Received11/14/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/23/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Death; Required Intervention;
Patient Age77 YR
Patient SexMale
-
-